Shopping Cart

There are no products in your cart.

Dr Adam Parslow

Postdoctoral Research Fellow | Microscopy Manager, ACRF Centre for Imaging the Tumour Environment

More about Dr Adam Parslow

The ability to translate our discoveries made at the laboratory bench to treatment for patients in our centre drives my passion to make an impact in our community.

I am an experienced molecular biologist, geneticist and advanced microscopy specialist. My research at the ONJCRI is based in the Tumour Targeting Laboratory, headed by Prof. Andrew Scott. We focus on the characterisation of cell surface receptors as targets for antibody-based cancer therapy. Through strong collaborations with medical chemists and clinical researchers, we are refining potential targets in order to improve treatments for aggressive cancer types, including glioblastoma, breast, and colorectal cancer.

I became the Foundation Manager of the newly established ACRF Centre for Imaging the Tumour Environment at the ONJCRI in late 2018. I am leading the ONJCRI research staff at this facility in utilising advanced microscopy technologies to visualise the interaction of cancer cells within their normal tissue environments. Discoveries made using these techniques will accelerate improvements in biomarker and treatment selection, which will ultimately lead to improved patient survival.

Education

PhD, Ludwig Institute for Cancer Research, Melbourne, Australia

Bachelor of Science (Honours), Department of Genetics, University of Melbourne

Current Appointments

Olivia Newton-John Cancer Research Institute, Melbourne

Honorary Associate, School of Cancer Medicine, La Trobe University, Melbourne

Achievements

Awarded Harold Mitchell Fellowship, 2018

Co-Founder and Co-Chair of the ONJCRI Postdoctoral Society, 2017-Present

Vice-President, La Trobe Institute for Molecular Science Postdoctoral Society, 2017

Awarded Kevinian Fellowship, St Kevin’s College Old Colleagians, 2017

Recipient of the Malcolm Ashbolt Postdoctoral Fellowship, 2014-2018

Ludwig Institute for Cancer Research PhD Student Medalist, 2010

10th Australian and New Zealand Zebrafish Workshop Presentation Award, 2009

11th Annual Australian Cell Cycle Workshop Presentation Award, 2008

Australian Postgraduate Award Scholarship NGED Cross-Disciplinary Workshop Award, 2008

Young Achievement Australia Biotechnology Entrepreneur Award, 2007

John A McKenzie/Selby Scientific Foundation Award, 2006

Dean of Science Honours List, University of Melbourne, 2006

Recent Publications

Parslow AC, Clayton AHA, Lock P, Scott AM. Confocal Microscopy Reveals Cell Surface Receptor Aggregation Through Image Correlation Spectroscopy. Journal of visualized experiments: 2018 Aug 2;(138). doi: 10.3791/57164.
Parslow AC, Parakh S, Lee FT, Gan HK, Scott AM. Antibody–Drug Conjugates for Cancer Therapy. Biomedicines 2016 Jul 11; 4 (3), 14.
Parslow A, Cardona A, Bryson-Richardson RJ. Sample Drift Correction Following 4D Confocal Time-lapse Imaging. Journal of Visualised Experiments. 2014, (86), e51086.
Burvenich IJG, …, Parslow AC, …, Scott AM. In vitro and in vivo evaluation of ⁸⁹Zr-DS-8273a as a Theranostic for anti-death receptor 5 therapy. Theranostics. 2016 Sep 25;6(12):2225-2234.
Sztal TE, …, Parslow AC, …, Bryson-Richardson RJ. Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function. Acta Neuropathol. 2015 Sep;130(3):389-406.

Ph: +61 3 9496 9100

Email: adam.parslow@onjcri.org.au